Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00788619 · ClinicalTrials.gov registry record · NA

Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization (IVF)

A NA study, sponsored by Johns Hopkins University.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT00788619: Clinical Trial NA study, sponsored by Johns Hopkins University.

NCT00788619 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00788619, a NA study, was terminated before completion, sponsored by Johns Hopkins University.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

Improvements in In-Vitro Fertilization (IVF) outcomes have largely been due to the generation of excess embryos allowing for multiple embryo transfer. Unfortunately this has also increased the risk of multiple pregnancy with associated maternal and neonatal morbidity and mortality. The investigators believe that the concentration of nitric oxide metabolites measured in the culture medium from the first day of culture can identify the best quality embryos allowing us to transfer a limited number of embryos without compromising the optimum chance for pregnancy.

Interventions

  • PROCEDURE Transfer of embryos on day 3 or day 5 after fertilization.
  • PROCEDURE Day 5 transfer

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2009-01
Est. Completion 2009-10
Phase NA
Johns Hopkins University

1,448 total trials

Why NCT00788619 stopped before completion

NCT00788619 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Transfer of embryos on day 3 or day 5 after fertilization. is the first listed.

NCT00788619 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00788619 about?

NCT00788619 is a clinical study titled "Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization (IVF)". Improvements in In-Vitro Fertilization (IVF) outcomes have largely been due to the generation of excess embryos allowing for multiple embryo transfer. Unfortunately this has also increased the risk of multiple pregnancy with associated maternal and neonatal morbidity and mortality. The investigators...

What is the current status of trial NCT00788619?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2009-01. Estimated completion is 2009-10.

What interventions are being tested in trial NCT00788619?

The interventions under investigation include: Transfer of embryos on day 3 or day 5 after fertilization. (PROCEDURE), Day 5 transfer (PROCEDURE).

Who is sponsoring clinical trial NCT00788619?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00788619's enrollment target sits among peer trials

2 1997th of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00788619, the US trial registry maintained by the National Library of Medicine. NCT00788619 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.